↓ Skip to main content

Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics

Overview of attention for article published in Italian Journal of Pediatrics, April 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter
9 tweeters

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
102 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics
Published in
Italian Journal of Pediatrics, April 2018
DOI 10.1186/s13052-018-0481-1
Pubmed ID
Authors

Luciana Indinnimeo, Elena Chiappini, Michele Miraglia del Giudice

Abstract

Acute asthma attack is a frequent condition in children. It is one of the most common reasons for emergency department (ED) visit and hospitalization. Appropriate care is fundamental, considering both the high prevalence of asthma in children, and its life-threatening risks. Italian Society of Pediatrics recently issued a guideline on the management of acute asthma attack in children over age 2, in ambulatory and emergency department settings. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was adopted. A literature search was performed using the Cochrane Library and Medline/PubMed databases, retrieving studies in English or Italian and including children over age 2 year. Inhaled ß2agonists are the first line drugs for acute asthma attack in children. Ipratropium bromide should be added in moderate/severe attacks. Early use of systemic steroids is associated with reduced risk of ED visits and hospitalization. High doses of inhaled steroids should not replace systemic steroids. Aminophylline use should be avoided in mild/moderate attacks. Weak evidence supports its use in life-threatening attacks. Epinephrine should not be used in the treatment of acute asthma for its lower cost / benefit ratio, compared to β2agonists. Intravenous magnesium solphate could be used in children with severe attacks and/or forced expiratory volume1 (FEV1) lower than 60% predicted, unresponsive to initial inhaled therapy. Heliox could be administered in life-threatening attacks. Leukotriene receptor antagonists are not recommended. This Guideline is expected to be a useful resource in managing acute asthma attacks in children over age 2.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 102 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 21%
Student > Master 11 11%
Other 10 10%
Student > Postgraduate 9 9%
Student > Doctoral Student 6 6%
Other 15 15%
Unknown 30 29%
Readers by discipline Count As %
Medicine and Dentistry 49 48%
Nursing and Health Professions 9 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 8%
Immunology and Microbiology 2 2%
Biochemistry, Genetics and Molecular Biology 1 <1%
Other 1 <1%
Unknown 32 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2018.
All research outputs
#3,164,837
of 13,644,402 outputs
Outputs from Italian Journal of Pediatrics
#74
of 500 outputs
Outputs of similar age
#79,571
of 271,820 outputs
Outputs of similar age from Italian Journal of Pediatrics
#1
of 1 outputs
Altmetric has tracked 13,644,402 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 500 research outputs from this source. They receive a mean Attention Score of 3.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,820 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them